Cargando…
Cognitive Behavioral Therapy Reduces Benzodiazepine Anxiolytics Use in Japanese Patients with Mood and Anxiety Disorders: A Retrospective Observational Study
PURPOSE: Benzodiazepines (BZDs) are prescribed to treat psychiatric diseases. However, many guidelines recommend limiting the use of BZDs because of side effects and lack of evidence regarding long-term efficacy. Moreover, reducing BZDs’ use is difficult because of dependency and the severity of wit...
Autores principales: | Nakajima, Aiichiro, Kanie, Ayako, Ito, Masaya, Hirabayashi, Naotsugu, Imamura, Fumi, Takebayashi, Yoshitake, Horikoshi, Masaru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509325/ https://www.ncbi.nlm.nih.gov/pubmed/32982251 http://dx.doi.org/10.2147/NDT.S263537 |
Ejemplares similares
-
Study protocol for a randomised controlled trial of cognitive processing therapy for post-traumatic stress disorder among Japanese patients: the Safety, Power, Intimacy, Esteem, Trust (SPINET) study
por: Ito, Masaya, et al.
Publicado: (2017) -
Cognitive behavioral therapy for depression in Japanese Parkinson’s disease patients: a pilot study
por: Shinmei, Issei, et al.
Publicado: (2016) -
Japan Unified Protocol Clinical Trial for Depressive and Anxiety Disorders (JUNP study): study protocol for a randomized controlled trial
por: Ito, Masaya, et al.
Publicado: (2016) -
An Evaluation of Family-Based Treatment for OCD in Japan: A Pilot Randomized Controlled Trial
por: Kobayashi, Yuki, et al.
Publicado: (2020) -
Prevalence and comorbidity of the ICD-11 and DSM-5 for PTSD caseness with previous diagnostic manuals among the Japanese population
por: Oe, Misari, et al.
Publicado: (2020)